Navigation Links
Cardium Reports on Third Quarter 2010 Financial Results and Recent Developments
Date:11/9/2010

dence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission.  We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after the date hereof.Copyright 2010 Cardium Therapeutics, Inc.  All rights reserved.For Terms of Use Privacy Policy, please visit www.cardiumthx.com.Cardium Therapeutics™ Generx® and MedPodium™ are trademarks of Cardium Therapeutics, Inc.Tissue Repair™, Gene Activated Matrix™, GAM™, Excellagen™, Excellarate™, Osteorate™, Appexium™ and Linee™ are trademarks of Tissue Repair Company. (Other trademarks belong to their respective owners)- Continued -Cardium Therapeutics, Inc.Selected Condensed Consolidated Balance Sheet DataSeptember 30,

2010

(Unaudited)December 31,

2009Cash and cash equivalents$
7,700,648$
3,363,665Restricted cash1,425,0001,425,000Accounts receivable-115,138Prepaid expenses and other current assets96,29140,384Property and equipment, net260,188351,539Other long-term assets179,938179,938Total assets$
9,662,065$
5,475,664Accounts payable and accrued liabilities$
,427,147$
2,637,243Derivative liabilities3,451,4674,802,882Long-term liabilities172,373190,114Total liabilities5,050,9877,630,239Stockholder's equity (deficiency)4,611,078(2,154,575)Total liabilities and stockholder's equity$
9,662,065$
5,475,664Selected Condensed Consolidated Results of OperationsThree months ended September 30,Nine months ended September 30,2010200920102009Revenues

$
-$   235,917$

'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Cardium to Present at the LifeTech Capital Miami Medical Investors Conference
2. Cardium Gains Exclusive Access to Novel Polymer-Based Nitric Oxide Technology for Expansion of Wound Healing Product Portfolio
3. Cardium to Present at 10th Annual Biotech in Europe Investor Forum
4. Cardium Regains Listing Compliance With NYSE Amex
5. Cardium to Present at MDB Capital Groups 2010 Bright Lights Conference
6. Cardiums Exchange Listing Compliance Plan Accepted by NYSE AMEX
7. Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
8. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
9. Cardium Completes $6.0 Million Registered Direct Offering
10. Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
11. Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... 21, 2015 Invetech , a ... automation, and contract manufacturing, and  NanoCellect Biomedical, ... and cell sorting technology for life science researchers, ... flow cytometry platform. Headquartered in ... developed a microchip-based cell sorting technology. NanoCellect,s flow ...
(Date:4/21/2015)... -- Tute Genomics, a leading provider of cloud-based genomic medicine technology, ... VP of Marketing. Mr. Forsythe is the latest to join ... commercial operations over the last two quarters. ... is a tremendous addition to the Tute Genomics team," stated ... "Josh,s vast experience commercializing software technology in a highly complex ...
(Date:4/21/2015)... RESEARCH TRIANGLE PARK, N.C. , April 21, 2015 ... announced today that it will release its first quarter ... 28, 2015. United Therapeutics will host a ... a.m. Eastern Time.  The teleconference is accessible by dialing ... the teleconference will be available for one week and ...
(Date:4/21/2015)... Whether it’s used for troubleshooting in a factory, ... Kessler CineDrive in a cinematic studio setting, or ... is designed to help any shooter create vivid high-speed ... the TS5-H offers the same convenient touchscreen controls and streamlined ... According to Tom Boldt for Fastec, “We believe that compelling ...
Breaking Biology Technology:NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 2NanoCellect And Invetech Announce Collaboration To Develop Novel Flow Cytometry Platform For Cell Sorting And Analysis 3Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 2Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 3Tute Genomics Continues Expansion of Genomic Medicine Commercial Operations; Appoints Josh Forsythe as New VP of Marketing 4Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 2Fastec Imaging Releases the TS5-H High Definition High-Speed Camera 3
... Oct. 11 Generex Biotechnology Corporation (Nasdaq: GNBT ... initiate a rights offering of common stock and warrants to ... a reverse stock split at the reconvened special meeting of ... 2010.  The amount of the offering has not been determined, ...
... for Global Health (BVGH) announced today that G. Steven ... and James A. Geraghty, Senior Vice President, Genzyme Corporation, ... of these two new board members rounds out the ... in emerging markets and public-private partnerships. "Both ...
... PharmaTech (NYSE: WX ), a leading pharmaceutical, ... with operations in China and the United States, today ... Negishi, and Dr. Akira Suzuki on winning the 2010 ... the development of palladium-catalyzed cross coupling, which has vastly ...
Cached Biology Technology:Generex Plans Rights Offering to Stockholders Following Reverse Stock Split 2Generex Plans Rights Offering to Stockholders Following Reverse Stock Split 3Burrill & Company CEO and Genzyme Executive Join BVGH Board of Directors 2Burrill & Company CEO and Genzyme Executive Join BVGH Board of Directors 3WuXi PharmaTech Congratulates the 2010 Nobel Laureates in Chemistry 2
(Date:3/23/2015)... March 23, 2015   HOYOS Labs , a ... today announced that the Company will demonstrate multiple biometrics-based ... and consumers at Connect:ID on March 23 through 25, ... Labs will highlight the IEEE Biometric Open Protocol Standard; ... and enterprise access control system. BOPS was invented by ...
(Date:3/20/2015)... DUBLIN , Mar. 20, 2015 Research ... announced the addition of the "India Sensors ... their offering. The sensor market is ... through 2020 Consumer electronics, automotive, industrial ... for sensors in the country. In addition, adoption ...
(Date:3/20/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced ... Business Report" report to their offering. This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5
... drinking water with chlorine boost the chances that pregnant ... of a major new study. If such threats exist ... it concludes. , The national study, directed by University ... earlier, less detailed work done in Northern California and ...
... developed by researchers at the University of Illinois at ... behavior of other molecules. , In previous DNA nanotechnology ... lattice to construct geometrical objects in three dimensions. Instead ... are using DNA to control the folding and resulting ...
... at the Universitat Autònoma de Barcelona has developed new ... same size and thickness as a fingernail and reduce ... minutes or a few hours, depending on each chain. ... ranging from paternity tests and identifying people to detecting ...
Cached Biology News:Major new UNC-based drinking water study suggests pregnancy fears may be overstated 2Major new UNC-based drinking water study suggests pregnancy fears may be overstated 3Health costs soar as 60 million Americans classed as obese 2New miniaturised chip dramatically reduces time taken for DNA analysis 2New miniaturised chip dramatically reduces time taken for DNA analysis 3
...
Practical tool for easy, effective sealing of 0.2ml PCR tubes and plates using cap strips....
Kit for testing the ability of a compound to simulate lipolysis in cultured human adipocytes. Kit contains controls, buffers and reagents for detecting glycerol and non-esterified free fatty acids. A...
... The TRAPeze RT Telomerase Detection ... in vitro assay for the ... quantification of telomerase activity. It ... TRAPeze assay and adds the ...
Biology Products: